NCT05394714 2025-09-23A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection StudyMedigen Biotechnology CorporationPhase 1 Recruiting18 enrolled
NCT06910514 2025-04-09Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic LesionsNakafarma S.L.Phase 3 Completed52 enrolled